Johnson & Johnson is fighting another shareholder proposal for an independent racial justice audit of the company.
New Brunswick, New Jersey–based J&J (NYSE:JNJ) defeated a similar measure at last year’s annual meeting of shareholders, though the vote was far from a landslide. The company also unsuccessfully petitioned the U.S. Securities and Exchange Commission to keep it off the ballot.
Now, an independent audit is again up for consideration at the April 28 annual meeting after surviving another J&J appeal to the SEC.
Proponents of the audit cite ongoing controversies over talcum powder allegedly marketed to minorities. They also point to the J&J Political Action Committee’s financial support of Republican members of Congress who voted to overturn President Joe Biden’s election after insurrectionists stormed the U.S. Capitol.
Get the full story at our sister site, Medical Design & Outsourcing.
Filed Under: MDO, Medical Design & Outsourcing
